Evidence map›Paper›PMID 41324214›Full record

ArticleJournal of musculoskeletal & neuronal interactions2025

Sarcopenia and Muscle Dysfunction in Osteogenesis Imperfecta: Insights from A Pilot Study.

Fatma Güntülü Değirmenci Karaahmetoğlu, Banu Ertürk, Alp Çetin, Ömer Alper Gürlek

Abstract read
In one paragraph

Article in Journal of musculoskeletal & neuronal interactions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatma Güntülü Değirmenci KaraahmetoğluHacettepe University, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
Banu ErtürkHacettepe University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey.
Alp ÇetinHacettepe University, Faculty of Medicine, Department of Physical Therapy and Rehabilitation, Ankara, Turkey.
Ömer Alper GürlekHacettepe University, Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to assess the prevalence of sarcopenia in adult patients with osteogenesis imperfecta (OI) and to identify its associated factors.

methodsSeventeen adult OI patients and 17 adult healthy controls matched for age, sex, and BMI were included. Assessments included handgrip strength (HGS), ultrasonographic muscle measurements, the International Physical Activity Questionnaire (IPAQ), Upper and Lower Extremity Functional Indices (UEFI & LEFI), the SARC-F questionnaire, and laboratory markers.

resultsLeft-handgrip strength was significantly lower in OI patients than in controls (21.8±4.9 kg vs. 25.3±4.2 kg, p = 0.034). Four OI patients had a SARC-F score ≥4, whereas none in the control group did. Handgrip strength was negatively correlated with thigh fat thickness (r = - 0.604, p = 0.010) and free T4 levels (p < 0.05) but positively correlated with gastrocnemius thickness, serum calcium, albumin, and triglycerides (p < 0.05).

conclusionRoutine muscle strength assessments should be considered an integral component of OI management to optimize patient outcomes. This work is a pilot, hypothesis‑generating study; its preliminary findings require confirmation in larger cohorts with formal power calculations.

Indexed as

Muscle, SkeletalOsteogenesis ImperfectaSarcopeniaAdultFemaleHand StrengthHumansMaleMiddle AgedPilot ProjectsYoung AdultHandgrip StrengthMuscle DysfunctionOsteogenesis ImperfectaSarcopenia

Identifiers

PMID41324214
PMCPMC12684263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.